Trestle Biotherapeutics

stem cells, biofabrication, implantable tissue

replacementreplacingtissue engineered

trestlebio.com·San Diego, California, United States·

01Overview 02People 03Projects 04Concepts 05Patents 06Public records 07Belief evolution

Plate C · C-F1AY

Projects

Renal tissue vascularization compositions and methods

preclinical

platform · high · Thu Apr 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Enable vascularization of renal tissues and associated in-vitro renal tissue compositions.

Patent-disclosed compositions and methods for vascularizing renal tissues and related in-vitro compositions.

Patent application WO2026076410A1 published on 2026-04-09 and listed as pending, assigned to Trestle Biotherapeutics Inc.

Implantable bioengineered therapeutic tissue for end stage renal disease

undisclosed

other · high

Develop implantable therapeutic kidney tissue intended to help patients with end stage renal disease get off dialysis, delay transplantation needs, and eventually support replacement-organ development.

Bioengineered therapeutic tissue integrating stem cell biology, biofabrication, fluidics, and cell manufacturing.

Company website describes active development of implantable therapeutic tissue for end stage renal disease.

Loading

Loading section...

0-100 chain-logic scale · 15 dimensions · scored on public evidence